Development Level

Tbio 120 | 11,445
Tchem 10 | 1,598
Tclin 6 | 613
Tdark 1 | 6,588

IMPC Phenotype

preweaning lethality, complete... 2 | 979
decreased T cell number 1 | 15
decreased bone mineral content 1 | 151
decreased circulating chloride... 1 | 30
decreased heart weight 1 | 27
decreased monocyte cell number 1 | 8
decreased vertical activity 1 | 208
embryonic growth retardation 1 | 106
embryonic lethality prior to o... 1 | 239
embryonic lethality prior to t... 1 | 278
hyperactivity 1 | 148
increased CD4-positive, alpha ... 1 | 4
increased circulating alkaline... 1 | 122
increased leukocyte cell numbe... 1 | 47
increased lymphocyte cell numb... 1 | 32
pallor 1 | 34
prenatal lethality prior to he... 1 | 87
prolonged PR interval 1 | 15

Disease

Cancer 96 | 2,499
diabetes mellitus 80 | 1,728
psoriasis 78 | 6,694
Ankylosing spondylitis 71 | 140
Behcet's disease 70 | 89
Hypersensitivity reaction type II disease 69 | 253
Carcinoma 65 | 11,493
Juvenile rheumatoid arthritis 63 | 111
Rheumatoid arthritis 63 | 1,191
Arthritis 62 | 290
Uveitis 59 | 103
Acquired immunodeficiency syndrome 58 | 197
Herpes zoster 57 | 68
Human immunodeficiency virus infectious disease 53 | 138
Psoriatic arthritis 53 | 86
Stevens-Johnson syndrome 51 | 92
dermatomyositis 46 | 966
Dermatitis 42 | 157
tuberculosis 42 | 2,010
Synovitis 37 | 78
Multiple Sclerosis 36 | 540
Behcet's syndrome 35 | 50
Congenital adrenal hyperplasia 35 | 73
Nephritis 35 | 51
Retinal vasculitis 35 | 36
Spondyloarthropathy, Susceptibility To, 1 35 | 35
Takayasu's arteritis 35 | 53
drug-induced hepatitis 35 | 44
ovarian cancer 34 | 8,520
lung cancer 33 | 4,740
Hepatitis B 29 | 108
glioblastoma 29 | 5,792
Kidney disease 28 | 430
Anemia 27 | 365
Liver disease 27 | 237
lung carcinoma 26 | 2,843
Leprosy 25 | 73
Astrocytoma, Pilocytic 24 | 3,081
Primary immunodeficiency disease 24 | 54
osteosarcoma 23 | 7,950
Hemochromatosis 22 | 54
invasive ductal carcinoma 22 | 2,951
Birdshot chorioretinopathy 21 | 23
Skin disease 21 | 66
adult high grade glioma 20 | 3,801
cutaneous lupus erythematosus 20 | 1,057
non-small cell lung cancer 19 | 2,890
interstitial cystitis 18 | 2,312
intraductal papillary-mucinous neoplasm (IPMN) 18 | 3,291
intraductal papillary-mucinous carcinoma (IPMC) 17 | 2,989
Berylliosis 16 | 28
Narcolepsy 16 | 72
Schizophrenia 16 | 1,160
ependymoma 16 | 4,679
intraductal papillary-mucinous adenoma (IPMA) 16 | 2,955
sarcoidosis 16 | 370
subependymal giant cell astrocytoma 16 | 2,287
Kidney cancer 15 | 2,613
Pre-Eclampsia 15 | 68
Systemic lupus erythematosus 15 | 194
breast carcinoma 15 | 1,638
Diffuse cutaneous systemic sclerosis 14 | 17
Human immunodeficiency virus type 1, susceptibility to 14 | 26
Multiple Sclerosis, Susceptibility to 14 | 15
Narcolepsy-cataplexy 14 | 21
Psoriasis susceptibility 1 14 | 14
astrocytoma 14 | 1,146
limited scleroderma 14 | 19
pancreatic cancer 14 | 2,398
Autosomal recessive predisposition 13 | 1,442
Rheumatoid Arthritis, Systemic Juvenile 13 | 16
Sarcoidosis 1 13 | 14
atypical teratoid / rhabdoid tumor 13 | 5,112
follicular lymphoma 13 | 20
malignant mesothelioma 13 | 3,232
primary Sjogren syndrome 13 | 735
primary pancreatic ductal adenocarcinoma 13 | 1,109
Duchenne muscular dystrophy 12 | 601
active ulcerative colitis 12 | 764
juvenile dermatomyositis 12 | 1,187
medulloblastoma, large-cell 12 | 6,241
Asthma 11 | 385
active Crohn's disease 11 | 922
ulcerative colitis 11 | 1,819
colon cancer 10 | 1,478
ductal carcinoma in situ 10 | 1,745
Bipolar Disorder 9 | 666
Breast cancer 9 | 3,578
Down syndrome 9 | 499
Multiple myeloma 9 | 1,332
adrenocortical carcinoma 9 | 1,428
esophageal adenocarcinoma 9 | 737
lung adenocarcinoma 9 | 2,716
Hypersensitivity 8 | 63
Liver Cirrhosis, Experimental 8 | 769
cystic fibrosis 8 | 1,696
group 3 medulloblastoma 8 | 4,104
group 4 medulloblastoma 8 | 1,855
head and neck cancer and chronic obstructive pulmonary disease 8 | 239
gastric carcinoma 7 | 807

Tissue

Liver and Pancreas 54 | 16,750
Digestive Tract 53 | 17,369
Endocrine System 53 | 18,159
Female tissues 53 | 17,400
Skin and soft tissues 53 | 17,230
Blood and immune system 52 | 16,909
Male tissues 52 | 17,142
Respiratory system 52 | 16,393
Cardiovascular System 51 | 15,192
Urinary Tract 51 | 16,678
Nervous System 48 | 16,725

Target Family

Non-IDG 127 | 12,091
Enzyme 7 | 4,145
Kinase 3 | 634

KEGG Pathway

Viral myocarditis 137 | 137
Metabolic pathways 1,263 | 1,263
Pathways in cancer 530 | 530
Olfactory transduction 414 | 414
Human papillomavirus infection 388 | 388
PI3K-Akt signaling pathway 349 | 349
HTLV-I infection 336 | 336
Endocytosis 310 | 310
MAPK signaling pathway 295 | 295
Epstein-Barr virus infection 280 | 280
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 267 | 267
Herpes simplex infection 262 | 262
Kaposi's sarcoma-associated he... 252 | 252
Viral carcinogenesis 251 | 251
Thermogenesis 232 | 232
Ras signaling pathway 230 | 230
Phagosome 229 | 229
Cellular senescence 228 | 228
Cell adhesion molecules (CAMs) 225 | 225
Rap1 signaling pathway 209 | 209
Regulation of actin cytoskelet... 207 | 207
cAMP signaling pathway 201 | 201
Focal adhesion 198 | 198
Proteoglycans in cancer 198 | 198
Natural killer cell mediated c... 197 | 197
Huntington's disease 194 | 194
Tuberculosis 189 | 189
Calcium signaling pathway 183 | 183
Chemokine signaling pathway 183 | 183
Influenza A 182 | 182
Axon guidance 174 | 174
Purine metabolism 172 | 172
Alzheimer's disease 171 | 171
Transcriptional misregulation ... 171 | 171
Tight junction 169 | 169
Hepatocellular carcinoma 168 | 168
NOD-like receptor signaling pa... 166 | 166
Protein processing in endoplas... 164 | 164
RNA transport 163 | 163
cGMP-PKG signaling pathway 162 | 162
Jak-STAT signaling pathway 161 | 161
Cushing's syndrome 158 | 158
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
Necroptosis 154 | 154
Oxytocin signaling pathway 154 | 154
MicroRNAs in cancer 150 | 150
mTOR signaling pathway 150 | 150
Non-alcoholic fatty liver dise... 149 | 149
Gastric cancer 148 | 148
Retrograde endocannabinoid sig... 148 | 148
Adrenergic signaling in cardio... 147 | 147
Alcoholism 147 | 147
Breast cancer 147 | 147
Phospholipase D signaling path... 147 | 147
Wnt signaling pathway 145 | 145
Hepatitis B 143 | 143
Parkinson's disease 142 | 142
Estrogen signaling pathway 139 | 139
Apoptosis 138 | 138
Fluid shear stress and atheros... 138 | 138
Signaling pathways regulating ... 138 | 138
Insulin signaling pathway 137 | 137
Ubiquitin mediated proteolysis 137 | 137
Apelin signaling pathway 136 | 136
Dopaminergic synapse 135 | 135
Ribosome 134 | 134
Measles 133 | 133
Oxidative phosphorylation 133 | 133
Relaxin signaling pathway 133 | 133
Spliceosome 132 | 132
Autoimmune thyroid disease 130 | 130
FoxO signaling pathway 130 | 130
Hepatitis C 130 | 130
Autophagy - animal 128 | 128
Osteoclast differentiation 127 | 127
Cell cycle 125 | 125
Platelet activation 125 | 125
Toxoplasmosis 125 | 125
Lysosome 123 | 123
Vascular smooth muscle contrac... 123 | 123
Type I diabetes mellitus 122 | 122
Oocyte meiosis 121 | 121
AMPK signaling pathway 120 | 120
Graft-versus-host disease 120 | 120
Neurotrophin signaling pathway 119 | 119
Th17 cell differentiation 119 | 119
Sphingolipid signaling pathway 118 | 118
Allograft rejection 116 | 116
Carbon metabolism 116 | 116
Glutamatergic synapse 116 | 116
Thyroid hormone signaling path... 116 | 116
Serotonergic synapse 114 | 114
Leukocyte transendothelial mig... 112 | 112
Cholinergic synapse 111 | 111
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
TNF signaling pathway 108 | 108
Insulin resistance 107 | 107

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
HLA class I histocompatibility antigen, B-35 alpha chain HLA-B Tbio Non-IDG -1.88752 1613.5 0
Abelson tyrosine-protein kinase 2 ABL2 Tchem Kinase -1.86293 71.2 358
Myosin-6 MYH6 Tbio Non-IDG -2.95952 901.3 45
HLA class I histocompatibility antigen, Cw-17 alpha chain HLA-C Tbio Non-IDG -1.90661 830.5 0
Actin, cytoplasmic 2 ACTG1 Tbio Non-IDG -2.50312 297.3 225
HLA class II histocompatibility antigen, DRB1-9 beta chain HLA-DRB1 Tbio Non-IDG 0.00000 0
HLA class I histocompatibility antigen, Cw-15 alpha chain HLA-C Tbio Non-IDG -1.90661 830.5 0
Perforin-1 PRF1 Tchem Non-IDG -3.20526 1546.3 367
CD40 ligand CD40LG Tbio Non-IDG -4.58203 37578.3 1461
HLA class II histocompatibility antigen, DRB1-14 beta chain HLA-DRB1 Tbio Non-IDG 0.00000 489